Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.335 USD | +2.62% | +5.66% | +122.52% |
04-17 | RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk | MT |
04-10 | Nuvation Bio Closes Acquisition of AnHeart Therapeutics | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+122.52% | 854M | |
+23.40% | 44.96B | |
+0.51% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.85% | 26.08B | |
-21.22% | 19.03B | |
+6.25% | 12.75B | |
+29.11% | 12.06B | |
-3.55% | 11.75B |
- Stock Market
- Equities
- NUVB Stock
- News Nuvation Bio Inc.
- Nuvation Bio Doses First Patient in Phase 1/2 Study of Advanced Solid Tumor Treatment